Home Careers Contact

Price: 3.15

Change: + 0.05

Day High: 3.20
Day Low: 3.05
Volume: 570,726

4:00 PM ET | Sep 22, 2017
Delayed 20 min., by eSignal.

Shareholder Tools

Committee Composition

  Audit Nominating and Governance Compensation
Garheng Kong, M.D., Ph.D Chairman of the Board Member of Audit Committee   Committee Chair for Compensation Committee
David Zaccardelli, Pharm.D.      
Richard Kent, M.D.     Member of Compensation Committee
David Gill Committee Chair for Audit Committee    
Dov A. Goldstein, M.D., M.B.A.   Committee Chair for Nominating and Governance Committee  
John H. Johnson   Member of Nominating and Governance Committee  

John H. Johnson has more than two decades of biopharmaceutical and healthcare industry experience. John H. Johnson was appointed senior vice president and president of the oncology business unit, Eli Lilly and Company, effective November 1, 2009. Prior to this appointment, he had served as chief executive officer of ImClone Systems since August 2007 and was also a member of ImClone's board of directors until the company became a wholly-owned subsidiary of Lilly in November 2008. Previously, he served as company group chairman of Johnson and Johnson's Worldwide Biopharmaceuticals unit and was responsible for the biotechnology, immunology and oncology commercial businesses, including Centocor, Ortho Biotech Products and the Worldwide Strategic Marketing Group. Mr. Johnson began his career at Pfizer and then joined Johnson and Johnson in 2000 to help lead the Company into the anti-infectives market. He left Johnson and Johnson in 2000 to join Parkstone Medical Information systems as president and CEO, returning in 2002 as worldwide vice president, CNS/Psychiatry. He was then appointed president of Ortho Biotech Products and subsequently became responsible for Ortho Biotech Canada until he was named company group chairman in 2005. Mr. Johnson earned a B.S. degree from East Stroudsburg University of Pennsylvania.

Holdings: 10,000 shares     View Transactions
P. Sherrill Neff     Member of Compensation Committee
Michael Dougherty Member of Audit Committee Member of Nominating and Governance Committee  
Chair of the Board = Chair of the Board Committee Chair = Chair of the Committee Committee Member = Member

Stock transaction information provided by EDGAR Online. Cempra, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.